Framework Convention on Tobacco Control
The World Health Organization Framework Convention on Tobacco Control (FCTC) was signed by 40 countries and the European Community during the first week it opened for signature. Norway became the first country to accept the treaty.
“The fact that so many countries signed the Framework Convention on Tobacco Control in its first week demonstrates how strongly it is supported and how meaningful it is to diverse populations and situations,” said Dr Gro Harlem Brundtland, Director-General, World Health Organization. “This group of early signatories is exemplary and others are encouraged to follow suit in the shortest possible time frame. It is only through a concerted worldwide effort that we can make global tobacco control happen. The benefits for health will be immense,” she added.
The FCTC’s demand and supply reduction measures will protect billions in present and future generations worldwide from the devastating impact of tobacco consumption and exposure to tobacco smoke. Tobacco kills nearly 5 million people per year. Unless strong action is taken, the global escalation in smoking, including amongst children, adolescents and women, will impose an even larger burden of disease, disability and death, particularly on developing countries.
The countries that have signed the FCTC to date are: Algeria, Bangladesh, Botswana, Brazil, Burundi, Czech Republic, Democratic People’s Republic of Korea, Denmark, Egypt, Finland, France, Gambia, Ghana, Greece, Hungary, Iceland, Islamic Republic of Iran, Israel, Italy, Kuwait, Luxembourg, Malta, Marshall Islands, Mauritius, Mongolia, Mozambique, Netherlands, New Zealand, Norway, Palau, Paraguay, Qatar, Senegal, South Africa, Spain, Sweden, Thailand, the United Kingdom, Uruguay and Yemen. The European Community signed the FCTC as a regional economic integration organization.
High level officials, including a vice president and ministers, from 28 countries, plus the European Community, signed the Convention at a formal ceremony at WHO’s Geneva headquarters on 16 June, the first day the treaty opened for signature.
In addition to signing the FCTC, Norway accepted it on 16 June. Ratifcation, acceptance, approval and accession are international acts by which states that have already signed the FCTC establish on the international plane their consent to be bound by it. As soon as 39 more countries follow suit, the Convention will become law for those countries and thereafter, for other countries that become contracting parties to it.
Deposited with United Nations Secretary-General Kofi Annan, the FCTC will be available for signature at the United Nations headquarters in New York from 30 June 2003 to 29 June 2004. Several more countries have informed WHO of their intention to sign the FCTC in New York shortly.
For more information contact:
Ms Melinda Henry
Telephone: +41 (22) 791 2535
Mobile phone: +41 (79) 477 1738
Fax: +41 (22) 791 4858
Email: henrym@who.int
Media Contact
More Information:
http://www.who.intAll latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Newest articles
You are What You Eat—Stanford Study Links Fiber to Anti-Cancer Gene Modulation
The Fiber Gap: A Growing Concern in American Diets Fiber is well known to be an important part of a healthy diet, yet less than 10% of Americans eat the minimum recommended…
Trust Your Gut—RNA-Protein Discovery for Better Immunity
HIRI researchers uncover control mechanisms of polysaccharide utilization in Bacteroides thetaiotaomicron. Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have identified a…
ASXL1 Mutation: The Hidden Trigger Behind Blood Cancers and Inflammation
Scientists show how a mutated gene harms red and white blood cells. LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have discovered how a mutated gene kicks off…